<DOC>
	<DOCNO>NCT02864017</DOCNO>
	<brief_summary>The main objective study demonstrate administration L-citrulline , improve immune function critically ill patient high risk nosocomial infection .</brief_summary>
	<brief_title>Immuno Nutrition L-citrulline Critically Ill Patients</brief_title>
	<detailed_description>This multicentric therapeutic trial , randomize double blind : standard enteral nutrition plus L-citrulline ( 5 grams/12 Hours 5 day admission Intensive Care Unit ( ICU ) ) versus standard enteral nutrition plus placebo . Methods-Patients : Non-surgical patient admit medical intensive care unit , mechanical ventilation expect duration &gt; 2 day , without severe sepsis septic shock , enrol . Symptoms lead ICU admission ongoing five day maximum . On admission ( treatment ) , severity evaluate Sepsis-related Organ Failure Assessment ( SOFA ) score together assessment plasmatic arginine , cytokine ( InterLeukin-6 ( IL6 ) ) , expression Human Leukocyte Antigen - antigen D Related ( HLA-DR ) monocytes . The evaluation repeat day 3 ( treatment ) day 7 ( treatment ) . The enrolment 100 patient statistically enough demonstrate decrease SOFA score L-citrulline group compare placebo group day 7 .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>age &gt; 18 year medical patient ( absence recent surgery trauma ) initial aggression &lt; 5 day mechanically ventilate expected duration mechanical ventilation &gt; 2 day exclusive enteral nutrition absence previous immunosuppression severe sepsis septic shock obesity define BMI 40 pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>